What is Graticule?
Graticule operates as a sophisticated data network operator and evidence generator, bridging the gap between complex health system data and actionable clinical insights. The firm specializes in real-world data solutions, providing a comprehensive suite of services that includes advanced data sourcing, feasibility studies, and precision patient screening. By partnering with hospitals and health systems worldwide, Graticule facilitates the seamless integration of new treatment options into clinical workflows. This market position is vital for accelerating research innovation, as the company effectively addresses the persistent challenges associated with data fragmentation and analysis in global real-world evidence studies. Their platform serves as a catalyst for improved patient outcomes and more efficient clinical trial execution.
How much funding has Graticule raised?
Graticule has raised a total of $83K across 1 funding round:
Debt
$83K
Debt (2021): $83K with participation from PPP
Key Investors in Graticule
PPP
Public-Private Partnership
What's next for Graticule?
With the infusion of this recent capital, Graticule is expected to prioritize the expansion of its global data network and the enhancement of its proprietary evidence generation platform. Strategic focus will likely shift toward deepening partnerships with international health systems to broaden the scope of their precision patient screening capabilities. As the demand for high-fidelity real-world evidence continues to rise within the pharmaceutical and biotech sectors, Graticule is poised to leverage its current momentum to capture additional market share. Future growth initiatives will likely involve scaling their technical infrastructure to support larger, more complex clinical trials, thereby reinforcing their status as a leader in the health-tech data ecosystem.
See full Graticule company page
